Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

AKYA Insider Trading

AKYA | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at AKYA provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2024-06-12 23:01 2024-06-11 McKelligon Brian Director, Officer - President and CEO OPT+S $2.08 7,500 $15,630 224,733 0.0%
2024-06-08 04:56 2024-06-06 McKelligon Brian Director, Officer - President and CEO OPT+S $2.01 7,500 $15,064 224,733 0.0%
2024-03-23 00:54 2024-03-20 McKelligon Brian Director, Officer - President and CEO OPT+S $4.97 7,500 $37,243 231,868 0.0%
2024-03-23 00:51 2024-03-13 McKelligon Brian Director, Officer - President and CEO OPT+S $4.94 7,500 $37,043 231,868 0.0%
2024-03-15 03:41 2024-03-13 McKelligon Brian Director, Officer - President and CEO SELL $4.94 7,500 $37,035 224,368 -3.2%
2023-12-21 03:16 2023-12-19 McKelligon Brian Director, Officer - President and CEO OPT+S $4.48 7,500 $33,566 152,563 0.0%
2023-12-15 00:24 2023-12-12 McKelligon Brian Director, Officer - President and CEO OPT+S $4.25 7,500 $31,871 152,563 0.0%
2023-11-23 00:00 2023-11-20 McKelligon Brian Director, Officer - President and CEO OPT+S $4.39 7,500 $32,901 152,563 0.0%
2023-09-11 23:00 2023-09-07 Pla Frederic Officer - Chief Operating Officer BUY $4.60 20,000 $92,014 20,000 +100.0%
2023-06-13 01:18 2023-06-12 Ek John Frederick Officer - CFO BUY $5.00 20,000 $100,000 20,000 +100.0%
2023-06-13 01:16 2023-06-12 Winkler Matthew Director BUY $5.00 203,388 $1,016,940 984,513 +26.0%
2023-06-13 01:17 2023-06-12 Mendel Scott Director BUY $5.00 20,000 $100,000 28,500 +235.3%
2023-06-13 01:15 2023-06-12 Raffin Thomas A. Director BUY $5.00 2,020,000 $10,100,000 15,937,535 +14.5%
2023-06-13 01:18 2023-06-12 LAI GOLDMAN MYLA Director BUY $5.00 20,000 $100,000 20,000 +100.0%
2023-06-13 01:16 2023-06-12 SHEPLER ROBERT G Director BUY $5.00 120,000 $600,000 369,592 +48.1%
2023-06-07 04:45 2023-06-06 McKelligon Brian Director, Officer - President/CEO OPT+S $5.71 5,000 $28,537 152,563 0.0%
2023-03-28 03:12 2022-12-13 Nolan Garry Ph.D. Director SELL $13.25 100 $1,325 555,084 0.0%
2023-03-16 23:20 2023-03-14 McKelligon Brian Director, Officer - President/CEO OPT+S $9.17 5,000 $45,852 160,000 0.0%
2022-12-21 00:02 2022-12-13 SCHNETTLER THOMAS P Director SELL $13.03 71,050 $925,782 2,742,721 -2.5%
2022-12-17 01:59 2022-12-14 DRISCOLL JOSEPH Officer - Chief Financial Officer OPT+S $12.54 24,613 $308,706 12,500 0.0%
2022-12-16 03:07 2021-12-13 Nolan Garry Ph.D. Director SELL $13.25 100 $1,325 555,084 0.0%
2022-12-09 00:01 2022-12-06 McKelligon Brian Officer - President/CEO OPT+S $12.08 5,000 $60,415 80,000 0.0%
2022-12-07 02:29 2022-12-02 Nolan Garry Ph.D. Director SELL $13.25 1,100 $14,575 591,978 -0.2%
2022-12-03 00:00 2022-12-01 Nolan Garry Ph.D. Director SELL $13.36 5,000 $66,788 593,078 -0.8%
2022-11-18 02:21 2022-11-16 Nolan Garry Ph.D. Director SELL $13.25 300 $3,976 598,078 -0.1%
2022-11-15 02:43 2022-11-10 Nolan Garry Ph.D. Director SELL $13.29 24,410 $324,529 598,378 -3.9%
2022-09-17 02:07 2022-09-14 Nolan Garry Ph.D. Director SELL $13.26 8,305 $110,084 622,788 -1.3%
2022-09-13 23:07 2022-09-09 Nolan Garry Ph.D. Director SELL $13.31 23,991 $319,282 631,093 -3.7%
2022-09-09 23:00 2022-09-07 McKelligon Brian Officer - President/CEO OPT+S $12.83 5,000 $64,170 80,000 0.0%
2022-06-17 23:08 2022-06-15 McKelligon Brian Officer - President/CEO OPT+S $10.25 5,000 $51,260 80,000 0.0%
2021-12-14 02:06 2021-12-09 Nolan Garry Ph.D. Director SELL $12.67 25,000 $316,763 655,084 -3.7%
2021-11-23 04:27 2021-11-19 Ramachandran Niro Ph.D Officer - Chief Business Officer BUY $13.13 25,073 $329,231 25,073 +100.0%
2021-11-19 20:55 2021-11-19 Mendel Scott Director BUY $13.16 8,500 $111,860 8,500 +100.0%
2021-11-19 05:08 2021-11-18 SHEPLER ROBERT G Director BUY $12.60 35,000 $441,004 35,000 +100.0%
SHOW ENTRIES

How to Interpret $AKYA Trades

Not every insider transaction in AKYA is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $AKYA shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for AKYA

Insider activity data for AKYA is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $AKYA, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.